Latest IJMSC Research Findings – September 2024: Key Insights and Trends

Here’s the latest research on multiple sclerosis (MS) from the International Journal of MS Care.

A study from Brazil found a high rate of preexisting conditions in people with MS. These conditions included cardiovascular issues, migraines, psychiatric disorders, autoimmune diseases, and respiratory problems. The study linked these comorbidities to a greater risk of disability progression. It highlighted the need for early identification and management to improve patient outcomes. Local environment, healthcare access, and demographic differences may also affect comorbidity rates and MS progression.

Another study from the University of North Carolina Hospitals Neurology Clinic looked at delays in starting disease-modifying therapies (DMT) for patients newly diagnosed with MS or transitioning care. Main delays were due to the need for baseline imaging, lab work, and specialist referrals. Although there were high rates of DMT discussions and prescriptions, the average time for medication approval was about nine weeks. Barriers included prior authorization processes and financial issues.

A case report from Iran showed that an occupation-based intervention can help individuals with MS. Using various outcome measures, participants showed improvements in occupational performance, satisfaction, and hand dexterity.

A study from the University of Washington explored how people with MS perceive their risk of victimization, especially those using assistive devices (AD). Individuals with previous trauma and more severe physical disabilities felt a higher risk of being targeted. AD use increased this perception. Participants from racial or ethnic minority groups using ADs reported the most vulnerability, linking it to a reduced sense of control in daily activities. Although many did not feel at high risk, some expressed fears of serious crimes like assault.

For more updates, visit the IJMSC website for new research.